ACE/ARB-COVID-19 - A Nordic population registry study of ACE inhibitors/ARBs and SARS-CoV-2 infection severity
- Funded by Nordic Trial Alliance (NTA)
- Total publications:0 publications
Grant number: Unknown
Grant search
Key facts
Disease
COVID-19Start & end year
N/AKnown Financial Commitments (USD)
$0Funder
Nordic Trial Alliance (NTA)Principal Investigator
Marte Helene BjørnResearch Location
NorwayLead Research Institution
University of Bergen, NorwayResearch Priority Alignment
N/A
Research Category
Epidemiological studiesResearch Subcategory
Disease susceptibilitySpecial Interest Tags
N/AStudy Type
UnspecifiedClinical Trial Details
N/ABroad Policy Alignment
PendingAge Group
UnspecifiedVulnerable Population
UnspecifiedOccupations of Interest
Unspecified